☰

Kenneth H. Warrington, Ph.D. - Publications

Affiliations: 
2000 University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Pharmacology, Toxicology, Oncology
Tree Info Grants Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Zolotukhin I, Luo D, Gorbatyuk O, Hoffman B, Warrington K, Herzog R, Harrison J, Cao O. Improved Adeno-associated Viral Gene Transfer to Murine Glioma. Journal of Genetic Syndromes & Gene Therapy. 4. PMID 24319629 DOI: 10.4172/2157-7412.1000133  0.489
2009 Laughlin KM, Luo D, Liu C, Shaw G, Warrington KH, Law BK, Harrison JK. Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest Differentiation. 78: 35-44. PMID 19427096 DOI: 10.1016/J.Diff.2009.04.001  0.42
2009 Laughlin KM, Luo D, Liu C, Shaw G, Warrington KH, Qiu J, Yachnis AT, Harrison JK. Hematopoietic- and neurologic-expressed sequence 1 expression in the murine GL261 and high-grade human gliomas. Pathology Oncology Research : Por. 15: 437-44. PMID 19145478 DOI: 10.1007/S12253-008-9147-4  0.431
2009 Levy HC, Bowman VD, Govindasamy L, McKenna R, Nash K, Warrington K, Chen W, Muzyczka N, Yan X, Baker TS, Agbandje-McKenna M. Heparin binding induces conformational changes in Adeno-associated virus serotype 2. Journal of Structural Biology. 165: 146-56. PMID 19121398 DOI: 10.1016/J.Jsb.2008.12.002  0.324
2008 Zhong L, Li B, Mah CS, Govindasamy L, Agbandje-McKenna M, Cooper M, Herzog RW, Zolotukhin I, Warrington KH, Weigel-Van Aken KA, Hobbs JA, Zolotukhin S, Muzyczka N, Srivastava A. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proceedings of the National Academy of Sciences of the United States of America. 105: 7827-32. PMID 18511559 DOI: 10.1073/Pnas.0802866105  0.452
2007 Wu J, Zhao W, Zhong L, Han Z, Li B, Ma W, Weigel-Kelley KA, Warrington KH, Srivastava A. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity. Human Gene Therapy. 18: 171-82. PMID 17328683 DOI: 10.1089/Hum.2006.088  0.446
2006 Zhao W, Zhong L, Wu J, Chen L, Qing K, Weigel-Kelley KA, Larsen SH, Shou W, Warrington KH, Srivastava A. Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors. Virology. 353: 283-93. PMID 16828834 DOI: 10.1016/J.Virol.2006.04.042  0.501
2006 Warrington KH, Herzog RW. Treatment of human disease by adeno-associated viral gene transfer. Human Genetics. 119: 571-603. PMID 16612615 DOI: 10.1007/S00439-006-0165-6  0.413
2006 Zhong L, Li W, Li Y, Zhao W, Wu J, Li B, Maina N, Bischof D, Qing K, Weigel-Kelley KA, Zolotukhin I, Warrington KH, Li X, Slayton WB, Yoder MC, et al. Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5. Human Gene Therapy. 17: 321-33. PMID 16544981 DOI: 10.1089/Hum.2006.17.321  0.472
2006 Teschendorf C, Warrington KH, Shi W, Siemann DW, Muzyczka N. Recombinant adeno-associated and adenoviral vectors for the transduction of pancreatic and colon carcinoma. Anticancer Research. 26: 311-7. PMID 16475712  0.613
2006 Wu J, Zhao W, Zhong L, Warrington KH, Srivastava A. 741. Self-Complementary Adeno-Associated Virus Vectors: Packaging Capacity and Purity Molecular Therapy. 13: S286. DOI: 10.1016/J.Ymthe.2006.08.823  0.431
2006 Kay J, Gouze E, Warrington K, Zolotukhin I, Watson R, Bush M, Saran J, Gouze J, McCarty D, Robbins P, Evans C, Ghivizzani S. 1094. Self-Complementary Vectors Significantly Enhance AAV-Mediated Gene Transfer to Joint Tissues Molecular Therapy. 13: S420-S421. DOI: 10.1016/J.Ymthe.2006.08.1197  0.472
2005 Kohlbrenner E, Aslanidi G, Nash K, Shklyaev S, Campbell-Thompson M, Byrne BJ, Snyder RO, Muzyczka N, Warrington KH, Zolotukhin S. Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 1217-25. PMID 16213797 DOI: 10.1016/J.Ymthe.2005.08.018  0.444
2005 Gigout L, Rebollo P, Clement N, Warrington KH, Muzyczka N, Linden RM, Weber T. Altering AAV tropism with mosaic viral capsids. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 856-65. PMID 15922956 DOI: 10.1016/J.Ymthe.2005.03.005  0.468
2005 Muzyczka N, Warrington KH. Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism. Human Gene Therapy. 16: 408-16. PMID 15871672 DOI: 10.1089/Hum.2005.16.408  0.493
2005 Kohlbrenner E, Aslanidi G, Nash K, Shklayev S, Campbell-Thompson M, Byrne BJ, Snyder RO, Muzyczka N, Warrington KH, Zolotukhin S. 400. Successful Production of Pseudotyped Mosaic rAAV Vectors Using a Modified Baculovirus Expression System Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.403  0.449
2004 Warrington KH, Gorbatyuk OS, Harrison JK, Opie SR, Zolotukhin S, Muzyczka N. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. Journal of Virology. 78: 6595-609. PMID 15163751 DOI: 10.1128/Jvi.78.12.6595-6609.2004  0.367
2003 Loiler SA, Conlon TJ, Song S, Tang Q, Warrington KH, Agarwal A, Kapturczak M, Li C, Ricordi C, Atkinson MA, Muzyczka N, Flotte TR. Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Therapy. 10: 1551-8. PMID 12907946 DOI: 10.1038/Sj.Gt.3302046  0.343
2003 Opie SR, Warrington KH, Agbandje-McKenna M, Zolotukhin S, Muzyczka N. Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. Journal of Virology. 77: 6995-7006. PMID 12768018 DOI: 10.1128/Jvi.77.12.6995-7006.2003  0.343
2002 Teschendorf C, Warrington KH, Siemann DW, Muzyczka N. Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus. Anticancer Research. 22: 3325-30. PMID 12530082  0.533
2002 Xiao W, Warrington KH, Hearing P, Hughes J, Muzyczka N. Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2. Journal of Virology. 76: 11505-17. PMID 12388712 DOI: 10.1128/Jvi.76.22.11505-11517.2002  0.335
2000 Siemann DW, Warrington KH, Horsman MR. Targeting tumor blood vessels: an adjuvant strategy for radiation therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 57: 5-12. PMID 11033183 DOI: 10.1016/S0167-8140(00)00243-7  0.476
1998 Warrington KH, Teschendorf C, Cao L, Muzyczka N, Siemann DW. Developing VDEPT for DT-diaphorase (NQO1) using an AAV vector plasmid. International Journal of Radiation Oncology, Biology, Physics. 42: 909-12. PMID 9845120 DOI: 10.1016/S0360-3016(98)00357-5  0.579
Show low-probability matches.